Article

Dr. David Weidig Addresses Discharge Planning Initiatives in Pulmonary Medicine

Conference|ATS: American Thoracic Society International Conference

David Weidig, MD, System Director of Hospital Medicine, Aurora Medical Group, Milwaukee, WI, says that readmissions are not necessarily a failure of medical treatment, but a failure of psycologic and social support systems for the patient that are not addressed while the patient is hospitalized.

David Weidig, MD, System Director of Hospital Medicine, Aurora Medical Group, Milwaukee, WI, says that readmissions are not necessarily a failure of medical treatment, but a failure of psycologic and social support systems for the patient that are not addressed while the patient is hospitalized. Dr Weidig states that the Society of Hospital Medicine's Project BOOST is a program that will allow people to look at tools that address the risks and issues that are key factors in readmission.

This video was taken on May 19, 2013, at the ATS 2013 International Conference in Philadelphia, PA.

Related Videos
Douglas Flora, MD, FACCC
Molly Dean, MSW, Siftwell
Bridgette J. Picou, LVN, ACLPN, The Well Project
Priscilla Tsondai, MD, MPH, IAS/CIPHER
Mia Moore, PhD, Fred Hutch Cancer Center
Steven Daniel Daveluy, MD, FAAD
Shawn Kwatra, MD, FAAD
Elizabeth Jones, MD, FAAD.
Brittany Craiglow, MD, FAAD
Related Content
Lynae Darbes, PhD, University of Michigan School of Nursing
March 12th 2025

Couples Counseling Key to HIV Prevention and Maternal Care

Maggie L. Shaw Lynae Darbes, PhD
Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples living in Kenya.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
DoxyPEP | Image credit: Rizwanvet - stock.adobe.com
March 12th 2025

Implementation, Adherence to DoxyPEP Remains Low in At-Risk Groups

Julia Bonavitacola
Patients in Washington D.C. and San Francisco had minimal early uptake and adherence to doxycycline post-exposure prophylaxis (DoxyPEP) in studies presented at the Conference on Retroviruses and Opportunistic Infections 2025.
Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care
February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones
George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.
Long COVID | Image credit: Parradee – stock.adobe.com
March 11th 2025

Studies Highlight Lingering Risks and Disparities of Long COVID

Hayden E. Klein
Long-term effects of COVID-19 include lingering symptoms that take months to improve, more severe illness for cancer survivors, and a higher risk of death after infection for people living in rural areas.
Person pushing button with slight frowning face | Image credit: EDER – stock.adobe.com
March 11th 2025

Americans Give US Health Care System a C Grade, Calling for Policy Change

Hayden E. Klein
A new report shows most Americans believe the government is too involved in health care regulation and want to see a ban on pharmaceutical company advertisements in the US.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo